|
Angeles
Vision Clinic
The web
site has detailed information on many other eye conditions. Please feel
free to visit our Home
Page or check out other
eye conditions on our Eye
Conditions page or Glaucoma
Page.
GLAUCOMA
TREATMENT DURING PREGNANCY AND BREASTFEEDING
Many medicines are known to
have adverse effects during pregnancy; others are known to be safe, but in a
large number of cases there is no firm evidence to decide on risk or safety.
Drug molecules which are comparatively small can pass easily through the
placenta from the mother into the babies bloodstream. However, the quantity
of drug delivered in an eye drop is very small when compared with the amount
in a tablet. Drug molecules also pass into breast milk, especially those
which dissolve easily in fat. Drugs in breast milk may theoretically cause
hypersensitivity in the infant even when concentrations are too low for a
pharmacological effect.
It should
me kept in mind that: Drug research cannot be carried out in women who are or
might be pregnant, or who are breast feeding. The
drug manufacturers therefore cannot recommend the use of drugs in such
people. The use of any drug when pregnant or breast feeding must
be under the supervision of your eye care doctor.
The most important thing, if
you are pregnant or trying to conceive, is to consult your family practice
physician and your eye care provider about the
glaucoma eye drops (or tablets) which you are taking. Your doctor’s will
balance the potential benefits of medical treatment against any possible
risks to decide whether or not a particular drug should be used. An
alternative medication may be suggested, it is very important that glaucoma
treatment is not discontinued without consulting your eye care provider.
The eye drops and tablets
listed below may have effects on the developing baby during pregnancy or
breast feeding and, as with all drugs, should be discussed with your doctor’s
before use.
For safety the FDA has
categorized drugs as A, B, C, D and X; A poses the least risk, while X poses
the most. Drugs in categories A and B such as antihistamines,
antibiotics and vitamins are relatively safe in pregnant women.
Consider these drugs if the benefits outweigh the remote risks of fetal
harm. You cannot rule out risk with category C drugs. Category D
drugs show positive evidence of risk. Category X drugs are
contraindicated in pregnancy.
Beta blocking
Eye Drops:
Beta Blockers are class C
drugs. They have been noted to cause neonatal and postnatal bradycardia
and hypoglycemia. These can pass into the breast milk but it is
considered unlikely that they will cause serious adverse effects from normal
eye drop doses. However, their use should still be discussed with your eye
care doctor. Examples of these drops are: Timoptic, Ocupress, Betagan,
Betoptic, Metipranolol, and Cosopt.
Carbonic
Anhydrase Inhibitors (CIA):
CIS's are class C drugs. These
pass into breast milk and may reduce the milk supply. The British National
Formulary states "the amount is too small to be harmful to the
baby" however, the manufacture of Dorzolamide (Trusopt) advises against
use in pregnancy or during breast feeding. The use of these drugs must be
discussed with your doctor’s. Examples of these drugs are: Diamox Tablets,
Diamox SR Capsules, Daranide Tablets, Trusopt and Azopt Eye Drops and Cosopt
(part of this combo drug).
Adrenaline:
These are class C drugs. The eye drops could cause an increased heart
rate in the infant during breast feeding and their use must be discussed with
your doctor. Examples of these drugs are: Propine, Epinal, Eppy/N, , Epifrin,
and Glaucoma.
Pilocarpine:
Pilocarpine is a Class C drug. There is no evidence of risk to a baby
during pregnancy at the doses used for chronic glaucoma. The drug is known to
pass into breast milk but adverse effects are unlikely.
Alpha
Adrenergic:
Alphagan is a category B drug.
It is relatively safe to use in pregnancy. However, it can be related
to bracdycardia, hypertension and apnea in children younger than 2 months,
with the potential for toxicity in human breast milk; should be used
cautiously in lactating mothers.
Prostaglandins:
Prostaglandins are category C drugs. No adequate and well controlled
studies of prostaglandins in pregnant women are yet available. Exercise
caution in lactating mothers; we don not know whether prostaglandins are
excreted in human milk. Examples of these are Xalatan, Travatan,
Rescula and Lumigan.
| Drug Name |
FDA Category |
Pregnancy comment |
Breast feeding comment |
Suggestion |
| Iopidine or Apraclonidine |
C |
Embryocidal at 60 MHROD |
Unknown |
Caution in nursing mothers. |
| Betoptic or Betaxolol |
C |
Post implantation loss at above 12
mg/kg. Not teratogenic and no adverse effects at sub toxic dose
levels. |
Unknown |
Caution in nursing mothers. |
| Lumigan or Bimatoprost |
C |
Abortion at 33 to 97 times the MHROD.
Teratotoxicity at 41 MHROD |
Excreted in breast milk in animals. |
Caution in nursing mothers. |
| Alphagan or Brimonidine |
B |
No impaired fertility or harm to fetus at
100 MHROD |
Excreted in breast milk in animals. |
Discontinue nursing or discontinue
medication where possible. |
| Azopt or Brinzolamide |
C |
Developmental toxicity and fetal
variations at 125 times MHROD. Decreased fetal weight |
Unknown. Decrease in body weight
with 312 MHROD |
Caution in nursing mothers. |
| Ocupress or Carteolol |
C |
Skeletal defects at 212 MHROD.
Resorptions at 1052 MHROD. Decreased fetal weight at 5264 MHROD |
Excreted in breast milk in animals. |
Caution in nursing mothers. |
| Propine or Dipivefrin |
B |
No adequate and controlled studies. |
Unknown |
Caution in nursing mothers. |
| Trusopt or Dorzolamide |
C |
Defects in vertebral bodies at 31 MHROD,
metabolic acidosis at this dosage. |
Decreases in body weight fain and delay in
postnatal development at 94 MHROD |
Extreme caution due to
risk for serious adverse reaction in nursing infant. |
| Xalatan or Latanoprost |
C |
Fetotoxicity at 80 times MHROD |
Unknown |
Caution in nursing mothers. |
| Betagan pr Levobunolol |
C |
Fetotoxicity at 80 times MHROD |
Unknown |
Caution in nursing mothers. |
| Optipranolol or Metipranolol |
C |
Fetotoxicity at 50mg/kg during
organogenesis. |
Unknown |
Caution in nursing mothers. |
| Pilocarpine |
C |
Unknown |
Unknown |
Caution in nursing mothers. |
| Timoptic or Timolol |
C |
Fetal resorptions increased at 100 to 1000
times MHROD |
Excreted in breast milk in animals. |
Discontinue nursing or discontinue
medication where possible. |
| Travatan or Travoprost |
C |
Teratogenic at 250 times MRHOD, skeletal
malformations. Post implantation losses greater at 7.5 to 75
MHROD. Not recommended in pregnancy or in women trying to become
pregnant. |
Excreted in breast milk in animals. |
Caution in nursing mothers. |
| Rescula or Unoprostone |
C |
Teratotoxicity and increased miscarriages
or resorption at 60 to 1000 times MHROD. |
Excreted in breast milk in animals. |
Caution in nursing mothers. |
MHROD=
normal levels
Contact Us
|